Rossari Biotech Ltd

Rossari Biotech Ltd has announced its 17th Annual General Meeting (AGM) will be held on Monday, July 20, 2026, at 11:00 AM IST. The meeting will be conducted entirely through Video Conferencing/Other Audio Visual Means (VC/OAVM). Key agenda items include the adoption of audited standalone and consolidated financial statements for the Financial Year 2025-26, declaration of a dividend of ₹0.50 per equity share, appointment of Mr. Edward Menezes as a director, and approval for material related party transactions with Unitop Chemicals Private Limited. The notice of the AGM is available on the company's website and forms part of the Integrated Annual Report for FY 2025-26.

Rossari Biotech Ltd has announced its Integrated Annual Report for the Financial Year 2025-26, coinciding with the 17th Annual General Meeting (AGM) scheduled for July 20, 2026. The AGM will be conducted via Video Conference. The report includes the Business Responsibility and Sustainability Report and is available on the company's website and MUFG's portal. The company also recommended a final dividend of ₹0.50 per equity share for FY24-25, with a record date of July 10, 2026. Members can exercise their voting rights electronically.

Rossari Biotech Ltd has informed the stock exchanges about the dispatch of letters to shareholders whose email addresses are not registered. These letters contain a weblink and QR code to access the Integrated Annual Report for FY 2025-26. The company's 17th Annual General Meeting (AGM) is scheduled for July 20, 2026, to be held via Video Conferencing. Key dates for the AGM include the last date for TDS exemption forms (July 10, 2026), record date for dividend entitlement (July 10, 2026), cut-off date for e-voting (July 13, 2026), and remote e-voting period from July 17 to July 19, 2026. Shareholders are advised to update their KYC and bank details for dividend credit.

Rossari Biotech Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as mandated by SEBI regulations. The report, integrated with the company's Annual Report, details its commitment to sustainability across environmental stewardship, social responsibility, and governance excellence. Key initiatives include renewable energy adoption, waste minimization, employee well-being programs, and robust governance frameworks. The company emphasizes that sustainability drives business transformation, innovation, and stakeholder confidence, positioning it for resilience and long-term growth in an evolving market.

Rossari Biotech Ltd's wholly-owned subsidiary, Unistar Thai Co. Limited, has established a new blending facility in Thailand. This facility boasts an installed capacity of 5000 MTPA and covers approximately 1,860 square meters. It is strategically positioned to serve as a regional technical hub, enhancing the company's ability to cater to the growing Southeast Asian market with customized formulations. The facility offers flexible manufacturing capabilities for powders, granules, and liquids, along with dedicated storage for raw materials, aiming to improve supply chain resilience and operational efficiency.

Rossari Biotech Limited has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will remain shut from July 01, 2026, until 48 hours after the announcement of the company's unaudited financial results for the quarter ending June 30, 2026. The specific date for the board meeting to approve these financial results will be communicated later.

Rossari Biotech Limited has announced that its 17th Annual General Meeting (AGM) will be held on Monday, July 20, 2026, at 11:00 AM IST via video conference. The company has also set Friday, July 10, 2026, as the record date for determining shareholder entitlement to any dividend declared for the financial year 2025-26. Additionally, Monday, July 13, 2026, is the cut-off date for remote and e-voting.

Rossari Biotech Limited has announced the record date for its final dividend as Friday, July 10, 2026. The 17th Annual General Meeting (AGM) is scheduled for Monday, July 20, 2026, where the dividend for the financial year 2025-26 will be proposed. The cut-off date for remote e-voting and e-voting during the AGM has been set for Monday, July 13, 2026. Payment of the dividend, if declared, will be subject to tax deductions and will be made within ten working days post-AGM.

Rossari Biotech Ltd. announced the grant of 830050 options under the Rossari Employee Stock Option Plan- 2019. This decision was made during a Board of Directors meeting held on May 27, 2026, following the ratification of the ESOP 2019 by the company's members on April 17, 2021, and based on the recommendation of the Nomination and Remuneration Committee. The board also approved the re-appointment of Ms. Esha Padmanabhan Achan as a Non-Executive Independent Director for a second term, subject to member approval.

Rossari Biotech Ltd has re-appointed Ms. Esha Padmanabhan Achan as a Non-Executive Independent Director for a second term of 3 years, commencing from October 21, 2026, to October 20, 2029, subject to members' approval. The board also approved the grant of 830050 stock options under the Rossari Employee Stock Option Plan – 2019.